CAS: 86639-63-6; 10-Aminocamptothecin

该化合物是长效异构酶I抑制剂的合成衍生物,通过稳定Topo异构体Asse I和DNA之间的共价综合体,表现出重要的抗突扰活动,导致叉子阻截和吸附性病复制.该复合物表明,与母分子相比,溶性和稳定性有所提高,提高了治疗应用潜力.临床研究表明,对一系列固态肿瘤,包括直肠癌和卵巢癌,具有效果.其行动和结构改变机制使它成为进一步研究肿瘤学的有希望的候选体,特别是克服与天然结肠癌相关的限制,如毒性和配方挑战.

结构式图片

上下游产品

CAS号86639-62-5 9-硝基喜树碱 | CAS号86639-48-7 喜树碱氮氧化物 | CAS号86639-72-7 (4R,5bS,11aS)-4... | CAS号7689-03-4 喜树碱 | CAS号173442-34-7 (S)-4-ethyl-4-h... | CAS号174092-80-9 (S)-4-Ethyl-4-h... | CAS号19685-09-7 (S)-10-羟基喜树碱 | CAS号19685-10-0 10-甲氧基喜树碱

合成工艺路线路线简述

  • 合成目标产物 9-Amino-20-Camptothecin 主要起始原料 10-Nitrocamptothecin
  • (文献来源)合成步骤主要原料 10-Nitrocamptothecin
📜喜树碱置于platinum(Iv) Oxide 吡啶,硫酸,氢气,硝酸,溶剂黄146,2,3-二氯-5,6-二氰基-1,4-苯醌体系中,用 1,4-二氧六环,乙醇 作为反应溶剂,70.0 °C,101.33 Kpa 条件下,反应 8.0H,反应生成 10-氨基喜树碱
参考文献:Synthesis And Antitumor Activity Of 20(S)-Camptothecin Derivatives: A-Ring Modified And 7,10-Disubstituted Camptothecins.
标题:Synthesis And Antitumor Activity Of 20(S)-Camptothecin Derivatives: A-Ring Modified And 7,10-Disubstituted Camptothecins.
摘要:在a环上具有硝基,氨基,氯,溴,羟基和甲氧基的20(S)-喜树碱衍生物被合成出来.通过在三氟乙酸中用四乙酸铅处理,B环氢化的喜树碱(2A)被转化为10-羟基喜树碱(6E).通过n-氧化物(9)的光反应得到了10-取代的衍生物(6).对a环修饰的喜树碱的细胞毒性进行了体外kb细胞和小鼠中的白血病l1210的评估.鉴定出7-乙基-10-羟基喜树碱(6I)作为一个有潜力的衍生物,可进一步进行修饰.
DOI:10.1248/cpb.39.3183

海关参考信息

专利信息


专利号:US-5212317-A
优先权日:1990-12-20
标 题:Methods and intermediates for the assymmetric synthesis of camptothecin and camptothecin analogs
发明人:COMINS DANIEL L; BAEVSKY MATTHEW F
权利人:UNIV NORTH CAROLINA STATE
摘要:Processes for making compounds of Formulae XIV, XV, and XVII ##STR1## wherein R 6 is lower alkyl, R 7 is lower alkyl, R is lower alkyl, Y is H, F or Cl, R 8 is a moiety of Formula XVIII ##STR2## wherein n is 1, 2, or 3, R 11 is C 1 -C 4 alkyl and R 12 is the same as R 11 , or R 11 and R 12 together form cyclopentane or cyclohexane, and R 13 is: n (a) phenyl substituted 1 to 5 times with C 3 -C 7 secondary alkyl or C 4 -C 7 tertiary alkyl, or n (b) selected from the group consisting of naphthyl, anthryl, and phenanthryl optionally substituted 1 to 5 times with C 3 -C 7 secondary alkyl or C 4 -C 7 tertiary alkyl groups, n R 10 is C 6 -C 10 alkyl, aryl or alkyl aryl, n and Y is H, F or Cl, n are disclosed. These processes can be used to make optically enhanced and optically pure forms of the compounds, which are useful in the making of camptothecin and analogs thereof.

专利号:US-5258516-A
优先权日:1990-12-20
标题 :Optically pure D,E ring intermediates useful for the synthesis of camptothecin and camptothecin analogs
发明人:COMINS DANIEL L; BAEVSKY MATTHEW F
权利人:NC STATE UNIVERSITY
摘要:Processes for making compounds of Formulae XIV, XV, and XVII ##STR1## wherein R 6 is lower alkyl, R 7 is lower alkyl, R is lower alkyl, Y is H, F or Cl, R 8 is a compound of Formula XVIII ##STR2## wherein n is 1, 2, or 3, R 11 is C 1 -C 4 alkyl and R 12 is the same as R 11 , or R 11 and R 12 together form cyclopentane or cyclohexane, and R 13 is: n (a) phenyl substituted 1 to 5 times with C 3 -C 7 secondary alkyl or C 4 -C 7 ; tertiary alkyl, or n (b) selected from the group consisting of naphthyl, anthryl, and phenanthryl optionally substituted 1 to 5 times with C 3 -C 7 secondary alkyl or C 4 -C 7 tertiary alkyl groups, n R 10 is C 6 -C 10 alkyl, aryl or alkyl aryl, n and Y is H, F or Cl, n are disclosed. These processes can be used to make optically enhanced and optically pure forms of the compounds, which are useful in the making of camptothecin and analogs thereof.

专利号:US-5254690-A
优先权日:1990-12-20
标 题 :Alkoxymethylpyridine d-ring intermediates useful for the synthesis of camptpthecin and camptothecin analogs
发明人:COMINS DANIEL L; BAEVSKY MATTHEW F
权利人:UNIV NORTH CAROLINA STATE
摘要:Compounds of Formula I ##STR1## are made in accordance with the following scheme: ##STR2## wherein R may be loweralkyl; R 1 may be H, loweralkyl, loweralkoxy, or halo; R 2 , R 3 , R 4 , and R 5 may each independently be H, amino, hydroxy, loweralkyl, loweralkoxy, loweralkylthio, di(loweralkyl)amino, cyano, methylenedioxy, formyl, nitro, halo, trifluoromethyl, aminomethyl, azido, amido, hydrazino, or any of the twenty standard amino acids bonded to the A ring via the amino-nitrogen atom; Y is H and W and X are halogen. Also disclosed are novel processes for making starting materials for the scheme given above, and novel intermediates employed in these processes.

专利号:US-5264579-A
优先权日:1990-12-20
标 题 :D ring intermediates for the synthesis of camptothecin and camptothecin analogs
发明人:COMINS DANIEL L; BAEVSKY MATTHEW F
权利人:UNIV NORTH CAROLINA STATE
摘要:Processes for making compounds of Formulae XIV, XV, and XVII ##STR1## wherein R 6 is lower alkyl, R 7 is lower alkyl, R is lower alkyl, Y is H, F or Cl, R 8 is a compound of Formula ##STR2## wherein n is 1, 2, or 3, R 11 is C 1 -C 4 alkyl and R 12 is the same as R 11 , or R 11 and R 12 together form cyclopentane or cyclohexane, and R 13 is: n (a) phenyl substituted 1 to 5 times with C 3 -C 7 secondary alkyl or C 4 -C 7 tertiary alkyl, or n (b) selected from the group consisting of naphthyl, anthryl, and phenanthryl optionally substituted 1 to 5 times with C 3 -C 7 secondary alkyl or C 4 -C 7 tertiary alkyl groups, n R 10 is C 6 -C 10 alkyl, aryl or alkyl aryl, and Y is H, F or Cl, are disclosed. These processes can be used to make optically enhanced and optically pure forms of the compounds, which are useful in the making of camptothecin and analogs thereof.

专利号:US-5315007-A
优先权日:1990-12-20
标 题:Process for making DE ring intermediates for the synthesis of camptothecin and camptothecin analogs
发明人:COMINS DANIEL L; BAEVSKY MATTHEW F
权利人:UNIV NORTH CAROLINA STATE
摘要:Processes for making compounds of Formulae XIV, XV, and XVII ##STR1## wherein R 6 is lower alkyl, R 7 is lower alkyl, R is lower alkyl, Y is H, F or Cl, R 8 is a compound of Formula XVIII ##STR2## wherein n is 1, 2, or 3, R 11 is C 1 -C 4 alkyl and R 12 is the same as R 11 , or R 11 and R 12 together form cyclopentane or cyclohexane, and R 13 is: n (a) phenyl substituted 1 to 5 times with C 3 -C 7 secondary alkyl or C 4 -C 7 tertiary alkyl, or n (b) selected from the group consisting of naphthyl, anthryl, and phenanthryl optionally substituted 1 to 5 times with C 3 -C 7 secondary alkyl or C 4 -C 7 tertiary alkyl groups, n R 10 is C 6 -C 10 alkyl, aryl or alkyl aryl, n and Y is H, F or Cl, n are disclosed. These processes can be used to make optically enhanced and optically pure forms of the compounds, which are useful in the making of camptothecin and analogs thereof.

专利号:US-5321140-A
优先权日:1990-12-20
标 题 :Pyridinecarboxaldehyde D-ring intermediates useful for the synthesis of camptothecin and camptothecin analogs
发明人:COMINS DANIEL L; BAEVSKY MATTHEW F
权利人:UNIV NORTH CAROLINA STATE
摘要:Compounds of Formula I ##STR1## are made in accordance with the following scheme: ##STR2## wherein R may be loweralkyl; R 1 may be H, loweralkyl, loweralkoxy, or halo; R 2 , R 3 , R 4 , and R 5 may each independently be H, amino, hydroxy, loweralkyl, loweralkoxy, loweralkylthio, di(loweralkyl)amino, cyano, methylenedioxy, formyl, nitro, halo, trifluoromethyl, aminomethyl, azido, amido, hydrazino, or any of the twenty standard amino acids bonded to the A ring via the amino-nitrogen atom; Y is H and W and X are halogen. Also disclosed are novel processes for making starting materials for the scheme given above, and novel intermediates employed in these processes.

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1016/s0378-4347(96)00426-4
摘要:Warner DL, Burke TG. Simple and versatile high-performance liquid chromatographic method for the simultaneous quantitation of the lactone and carboxylate forms of camptothecin anticancer drugs. Journal of Chromatography B: Biomedical Sciences and Applications. 1997 Mar;691(1):161–71. doi: 10.1016/s0378-4347(96)00426-4.
参考文献:10.1021/jm9902279
摘要:Bom D, Curran DP, Chavan AJ, Kruszewski S, Zimmer SG, Fraley KA, Burke TG. Novel A,B,E-ring-modified camptothecins displaying high lipophilicity and markedly improved human blood stabilities. J Med Chem. 1999 Aug 12;42(16):3018–22. doi: 10.1021/jm9902279.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知